FDA Investigator Holly Brevig

Holly Brevig has conducted inspections on 8 sites in 4 countries as of 20 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
8
Last Inspection Date:
20 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
100009459
Countries of Inspections:
United States of America, Switzerland, Japan, Austria
FDA Investigators that have inspected at least one site in common with Holly Brevig:
Abdur Rafay Shareef, Alan L Truong, Amber G Wardwell, Amir Alavi, Anastasia G Lolas, Angela E Glenn, Anita Narula, PhD, Ann M Stewart, Ann Marie Montemurro, Ann Marie Schofield, Anthony C Warchut, Arie C Menachem, Arsen Karapetyan, Barbara T Carmichael, Bingchen Du, PhD, Bradley Dworak, PhD, Brenda P King, Brentley S Collins, Bruce D Meade, Burnell M Henry, Carolyn A Renshaw, Cassandra L Abellard, CDR Donald Ertel, CDR Ileana Barreto Pettit, Chikako Torigoe, PhD, Christian D Lynch (CDL), Christine A Harman, PhD, Concepcion Cruz, Jr, Craig A Garmendia, Cynthia Jim, CSO, Cynthia L Kelley, David E Bailey, David Galler Veety, David J Gomes, Deborah M Trout, Dennis Cantellops Paite, Diane L Raccasi, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Dusty F Snoeberg, Ellen P Madigan, Gene D Arcy, George Pyramides, Gloria E Parra, Hector A Carrero, Irina Gaberman, Ivan E Reyes, Jacqueline Mdiaz Albertini, James L Dunnie, Jr, Jamie L Dion, Jean Lhu Primmer, Jennifer L Bridgewater, Joan Johnson, Jonathan G Matrisciano, Jose Acruz Gonzalez, José E Meléndez, Juanita P Versace, Julie D Bringger, Justin A Boyd, Katherine D Adams, Katie L Korchinski, Kenneth H Williams, Kevin A Gonzalez, Kham Phommachanh, Larry K Austin, Laurimer Kuilan Torres, Linda Thai, Lisa P Oakes, Lu Deng, Lucas B Leake, Malgorzata G Norton, PhD, Margaret Norton, Maria Cecilia Tami, PhD, Maria Joselopez Barragan, PhD, Marsha W Major, Mary E Farbman, PhD, Maya M Davis, Megan A Haggerty, Melissa D Ray, Michael A Charles, Michael C Kennedy, PhD, Michael E Maselli, Michele L Forster, PhD, Michele Perry Williams, Michelle Yclark Stuart, Mihaly S Ligmond, Mra Mcculloughj, Myra K Casey, Nicholas A Violand, Niketa Patel, Olga Simakova, PhD, Omotunde O Osunsanmi, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patricia F Hughes, PhD, Patrick L Wisor, Patsy J Domingo, Paul L Bellamy, Paula A Trost, Phillip E Mclaughlin, Prabhu P Raju, Prajakta A Varadkar, Raeann R Wu, Ram Sihag, PhD, Ramon E Martinez, Raquel Gonzalez Rivera, Rebecca E Dombrowski, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Robert Jennings, Rose Ashley, Samina S Khan, Sang Bong Lee, Santos E Camara, Sarah B Tanksley, Sharon K Thoma, PharmD, Sheri L Stephenson, Sidney B Priesmeyer, Stacey S Degarmo, Steven C Derrick, Steven Fong, MS, PhD, Steven M Weinman, Susan M Jackson, Susan M Turcovski, Tawny L Colling, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy M Martin, Tina M Pawlowski, Torrance J Slayton, Towanda L Terrell, Travis S Bradley, Valentino Fiorella, Vidya B Pai, Vincent Thomas, Vioela J Caze, Wayne E Seifert, William D Tingley, Xianghong Jing (Emily), PhD, Xiaokuang Lai, PhD, Yonggang Wang, PhD

Holly Brevig's Documents

Publish Date Document Type Title
October, 2019 FDA 483 Emergent Biodefense Operations Lansing LLC - Form 483, 2019-10-04
May, 2023 FDA 483 Takeda Pharmaceutical Company Limited - Form 483, 2023-05-24
February, 2024 FDA 483 ten23 health Valais AG - Form 483, 2024-02-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more